Genmab agreed to acquire Merus N.V., according to source material published on October 14, 2026. The reported purchase consideration is $8,000,000,000. This summary is limited to the approved transaction facts in the cited source evidence.
Genmab agreed to acquire Merus N.V.
Genmab agreed to acquire Merus N.V.
AcquisitionUSD8,000,000,000Hospitals and Health CareNL
Get the full Merus N.V. company profile
Access contacts, investors, buying signals & more
Acquired
Merus N.V.
The NetherlandsHospitals and Health Care
Deal value
USD8,000,000,000
October 14, 2026
Acquirer
Genmab
Biotechnology Research
Unlock GTM signals
Discover Merus N.V.'s tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Merus N.V..